Literature DB >> 16719783

Protein transduction: cell penetrating peptides and their therapeutic applications.

Kylie M Wagstaff1, David A Jans.   

Abstract

Cell penetrating proteins or peptides (CPPs) have the ability to cross the plasma membranes of mammalian cells in an apparently energy- and receptor-independent fashion. Although there is much debate over the mechanism by which this "protein transduction" occurs, the ability of CPPs to translocate rapidly into cells is being exploited to deliver a broad range of therapeutics including proteins, DNA, antibodies, oligonucleotides, imaging agents and liposomes in a variety of situations and biological systems. The current review looks at the delivery of many such molecules by various CPPs, and their potential therapeutic application in a wide range of areas. CPP ability to deliver different cargoes in a relatively efficient and non-invasive manner has implications as far reaching as drug delivery, gene transfer, DNA vaccination and beyond. Although many questions remain to be answered and limitations on the use of CPPs exist, it is clear that this emerging technology has much to offer in a clinical setting.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16719783     DOI: 10.2174/092986706776872871

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  42 in total

1.  Protein delivery using engineered virus-like particles.

Authors:  Stanislaw J Kaczmarczyk; Kalavathy Sitaraman; Howard A Young; Stephen H Hughes; Deb K Chatterjee
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

2.  A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription.

Authors:  Indrajit Das; Jérôme Désiré; Dinesh Manvar; Isabelle Baussanne; Virendra N Pandey; Jean-Luc Décout
Journal:  J Med Chem       Date:  2012-06-22       Impact factor: 7.446

3.  Internalization of biotinylated compounds into cancer cells is promoted by a molecular Trojan horse based upon core streptavidin and clostridial C2 toxin.

Authors:  Jörg Fahrer; Joschua Funk; Maren Lillich; Holger Barth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-07       Impact factor: 3.000

4.  Protein transfer into human cells by VSV-G-induced nanovesicles.

Authors:  Philippe-Emmanuel Mangeot; Sandra Dollet; Mathilde Girard; Claire Ciancia; Stéphane Joly; Marc Peschanski; Vincent Lotteau
Journal:  Mol Ther       Date:  2011-07-12       Impact factor: 11.454

5.  In Vivo Applications of Cell-Penetrating Zinc-Finger Transcription Factors.

Authors:  Chonghua Ren; Alexa N Adams; Benjamin Pyles; Barbara J Bailus; Henriette O'Geen; David J Segal
Journal:  Methods Mol Biol       Date:  2018

6.  Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34+ leukaemia cells.

Authors:  Marjan M Fretz; Neal A Penning; Saly Al-Taei; Shiroh Futaki; Toshihide Takeuchi; Ikuhiko Nakase; Gert Storm; Arwyn T Jones
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

7.  Effect of lipid headgroup charge and pH on the stability and membrane insertion potential of calcium condensed gene complexes.

Authors:  Nabil A Alhakamy; Ibrahim Elandaloussi; Saba Ghazvini; Cory J Berkland; Prajnaparamita Dhar
Journal:  Langmuir       Date:  2015-03-30       Impact factor: 3.882

8.  Interclass GPCR heteromerization affects localization and trafficking.

Authors:  Rudy Toneatti; Jong M Shin; Urjita H Shah; Carl R Mayer; Justin M Saunders; Miguel Fribourg; Paul T Arsenovic; William G Janssen; Stuart C Sealfon; Juan F López-Giménez; Deanna L Benson; Daniel E Conway; Javier González-Maeso
Journal:  Sci Signal       Date:  2020-10-20       Impact factor: 8.192

9.  Effects of TAT-conjugated platinum nanoparticles on lifespan of mitochondrial electron transport complex I-deficient Caenorhabditis elegans, nuo-1.

Authors:  Yuri Sakaue; Juewon Kim; Yusei Miyamoto
Journal:  Int J Nanomedicine       Date:  2010-09-20

10.  Arginine-rich, cell penetrating peptide-anti-microRNA complexes decrease glioblastoma migration potential.

Authors:  Yu Zhang; Melanie Köllmer; Jason S Buhrman; Mary Y Tang; Richard A Gemeinhart
Journal:  Peptides       Date:  2014-06-23       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.